表紙
市場調査レポート

喘息治療用ネブライザー・吸入器・人工呼吸器の世界市場

Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets

発行 BCC Research 商品コード 327449
出版日 ページ情報 英文
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
喘息治療用ネブライザー・吸入器・人工呼吸器の世界市場 Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets
出版日: 2015年03月30日 ページ情報: 英文
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界のネブライザー・吸入器・人工呼吸器の市場は2013年に約112億ドル、2014年には約124億ドルの規模を記録しました。2019年にかけては8.9%のCAGRで推移し、2019年には190億ドルの規模に成長すると予測されています。

当レポートでは、世界の喘息治療用ネブライザー・吸入器・人工呼吸器の市場について調査し、喘息治療デバイスの種類と概要、市場成長への影響因子および産業における課題の分析、技術動向、デバイスタイプ・地域別の市場規模の推移と予測、主要地域・国別の法規制および償還関連の動向、医療産業の動向、技術的発展の見通し、事業戦略の分析および提言、特許動向、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 サマリー

第3章 市場概要

  • 喘息の概要
  • ネブライザーについて
  • 吸入器について
  • 人工呼吸器について
  • 喘息治療デバイス
    • ネブライザー
    • 吸入器
    • 人工呼吸器
  • COPD (慢性閉塞性肺疾患) の概要

第4章 産業構造・課題・市場成長推進因子および阻害因子・技術動向

  • イントロダクション
  • 市場成長推進因子および阻害因子
  • 産業における課題
    • 環境面の課題
    • 遺伝的要因
  • 技術動向
    • スマートネブライザー
    • ネブライザーシステムの進歩
    • 吸入器
    • 喘息治療用ジェネリック薬
    • スマートコード技術
    • 気道におけるバクテリアへのリンク
    • よりスマートなドライパウダー吸入器

第5章 世界のネブライザー・吸入器・人工呼吸器市場

  • 世界の喘息への意識の変化
  • 世界市場:デバイスタイプ別
    • ネブライザー
    • 吸入器
    • 人工呼吸器
  • 喘息治療市場:地域別
    • ネブライザー
    • 吸入器
    • 人工呼吸器

第6章 特許

第7章 法規制・償還

  • 概要
  • 医療機器の自由販売証明
  • GHTF (GLOBAL HARMONIZATION TASK FORCE)
  • 国際医療機器規制当局フォーラム (INTERNATIONAL MEDICAL DEVICE REGULATORS FORUM)
  • 医療機器関連法規制:地域・国別
    • 北米
    • EU
    • アジア
    • 新興市場
  • 償還上の課題
    • 償還手続きの概要:地域・国別
  • 将来の技術開発
    • 気管支熱形成術 (BT:BRONCHIAL THERMOPLASTY)
    • ピモジドの研究
    • スマートネブライザー
    • OTC喘息吸入器
    • DOURESP SPIROMAX
    • ASTRAZENECAの新薬
    • 衛生仮説

第8章 北米・欧州・アジア・新興国における医療

  • 北米
  • 欧州
  • アジア
  • 新興国

第9章 市場戦略・戦略的提言

  • マーケティング戦略
  • 特許戦略
  • 主な懸念事項への対応
  • ジョイントベンチャー

第10章 現在の状況

  • 喘息の概要
  • 世界の喘息ネットワーク
  • 喘息治療デバイスで利用される薬剤
  • 肥満と呼吸器の疾患
  • 呼吸器疾患のための医療機器
    • ネブライザー
    • 吸入器
    • 人工呼吸器

第11章 企業プロファイル

  • 3M HEALTHCARE
  • ASTRAZENECA
  • BOEHRINGER INGELHEIM
  • DRAGER
  • GLAXOSMITHKLINE
  • INVACARE
  • OMRON
  • PHILIPS RESPIRONICS
  • PHILIPS HEALTHCARE
目次
Product Code: HLC177A

REPORT HIGHLIGHTS

The global market for nebulizers, inhalers and respirators has reached nearly $11.2 billion and $12.4 billion in 2013 and 2014, respectively. This market is expected to grow at compound annual growth rate (CAGR) of 8.9% to reach $19.0 billion in 2019.

This report provides:

  • An overview of the global markets for nebulizers, inhalers, and respirators used for Asthma treatment.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
  • Analysis of the market based on market share, product types, and geography.
  • Information on suppliers of asthmatic equipment and related devices.
  • Discussion on important manufacturers, technologies, and factors influencing demand.
  • Information pertaining to the industry's dynamics including market drivers, restraints, and opportunities.

SCOPE OF THE STUDY

The report is a comprehensive business tool designed to provide an in-depth look at equipment related to asthma. The report is global in geographical scope, with special emphasis on individual regions. The report describes the industry, its relationship to the healthcare sector, its participants and trends for the future.

Categories discussed in the report include:

  • Nebulizers.
  • Inhalers.
  • Respirators.

Factors discussed in the report include:

  • Air pollution and its causes and effects.
  • Genetics.
  • Obesity.
  • Other factors related to asthmatic conditions.

The report includes detailed discussion on topics that include description and identification of current products on the market, measuring market size, identification of market drivers and market forecasts from 2014 to 2019. Competitors and their market shares are assessed. At the country level, the market is broken down into segments, with 2013 as the base year and projections to 2019 indicated in data tables. Year-to-year differences are considered statistically insignificant.

The market evaluated in the study pertains to existing devices used to treat asthma that are developed and approved for human clinical use. Market size takes into account nebulizers, inhalers and respirators. Options and upgrades and refurbished and remarketed equipment have not been accounted for in the quantitative estimates and forecasts provided in the study. Ancillary products and services related to the relief of asthmatic conditions are discussed. Metrics at the country level are used to examine market dynamics and their impact on revenues and growth. Interviews were used to confirm and/or adjust market size and market share estimates as well as formulating market projections.

ANALYST'S CREDENTIALS

Smruti Munshi is a research analyst who has specialized in medical technologies for the last five years. She focuses on monitoring and analyzing emerging trends and technologies, competitive benchmarking and market dynamics within the medical devices industry. Smruti has worked on several projects spanning the Europe, Middle East and Africa markets, ranging from market insights and industry reviews to comprehensive marketing and technology-oriented custom consulting. She has an M.S. in biomedical engineering and a B.S. in instrumentation and control engineering.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR THE STUDY
  • SCOPE OF THE STUDY
  • INTENDED AUDIENCE
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR NEBULIZERS, INHALERS AND RESPIRATORS FOR TREATMENT OF ASTHMA BY REGION, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR NEBULIZERS, INHALERS AND RESPIRATORS FOR TREATMENT OF ASTHMA BY REGION, 2013-2019 ($ MILLIONS)

CHAPTER 3 - MARKET OVERVIEW

  • OVERVIEW OF ASTHMA
  • INTRODUCTION TO NEBULIZERS
  • INTRODUCTION TO INHALERS
    • TABLE 1: COLOR CODING OF INHALERS
  • INTRODUCTION TO RESPIRATORS
    • TABLE 2: NIOSH STANDARDS FOR PARTICULATE FILTER RESPIRATORS (%)
    • TABLE 3: EUROPEAN STANDARD EN143 RESPIRATOR FILTER (%)
    • TABLE 4: EUROPEAN STANDARD EN149 RESPIRATOR
    • TABLE 5: EUROPEAN STANARD EN136 FULL FACE MASK
  • APPLICATIONS OF ASTHMATIC TREATMENT DEVICES
    • NEBULIZERS
    • INHALERS
    • RESPIRATORS
  • OVERVIEW OF COPD

CHAPTER 4 - INDUSTRY STRUCTURE AND CHALLENGES, MARKET DRIVERS AND RESTRAINTS, AND TECHNOLOGY TRENDS

  • INTRODUCTION
  • MARKET DRIVERS AND MARKET RESTRAINTS
    • MARKET DRIVERS
      • Air Pollution
        • China
        • United States
        • Russia
        • India
        • Japan
        • Germany
        • Canada
        • United Kingdom
        • South Korea
        • Iran
      • Other Drivers
    • MARKET RESTRAINTS
  • INDUSTRY CHALLENGES
    • ENVIRONMENTAL FACTORS
      • TABLE 6: ENVIRONMENTAL PROTECTION AGENCY (EPA) AIR QUALITY INDEX
    • GENETIC FACTORS
  • TECHNOLOGY TRENDS
    • SMART NEBULIZERS
    • DEVELOPMENT OF NEBULIZER SYSTEMS
      • Smaller Nebulizers
      • Vibrating Mesh Technology
    • INHALERS
    • GENERICS FOR ASTHMA TREATMENTS
    • SMARTCODE TECHNOLOGY
    • LINK TO BACTERIAL COMMUNITIES IN THE AIRWAYS
    • SMARTER DRY POWDER INHALERS
      • Inspiromatic

CHAPTER 5 - GLOBAL MARKET FOR NEBULIZERS, INHALERS AND RESPIRATORS

  • CHANGING GLOBAL AWARENESS OF ASTHMA
  • GLOBAL MARKET BY DEVICE TYPE
    • NEBULIZERS
      • TABLE 7: COST OF INDIVIDUAL NEBULIZERS BY COUNTRY ($)
      • TABLE 8: GLOBAL MARKET FOR NEBULIZERS, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • FIGURE 1 GLOBAL MARKET FOR NEBULIZERS, 2013-2019 ($ MILLIONS)
    • INHALERS
      • TABLE 9: COST OF INHALERS BY COUNTRY ($)
      • Phasing Out CFC Inhalers
      • Corticosteroid Inhalers
      • Global Market For Inhalers
        • TABLE 10: GLOBAL MARKET FOR INHALERS, THROUGH 2019 ($ MILLIONS/THOUSANDS)
        • FIGURE 2: GLOBAL MARKET FOR INHALERS, 2013-2019 ($ MILLIONS)
    • RESPIRATORS
      • TABLE 11: COST OF RESPIRATORS BY COUNTRY ($)
      • TABLE 12: GLOBAL MARKET FOR RESPIRATORS, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • FIGURE 3: GLOBAL MARKET FOR RESPIRATORS, 2013-2019 ($ MILLIONS)
  • GROWTH OF ASTHMA BY REGION
    • GLOBAL MARKET FOR NEBULIZERS
      • TABLE 13: GLOBAL MARKET FOR NEBULIZERS BY REGION, THROUGH 2019 ($ MILLIONS)
      • TABLE 14: GLOBAL MARKET SHARES FOR NEBULIZERS BY REGION, 2013 (%)
      • TABLE 15: FORECAST GLOBAL MARKET SHARES FOR NEBULIZERS BY REGION, 2019 (%)
    • GLOBAL MARKET FOR INHALERS
      • TABLE 16: GLOBAL MARKET FOR INHALERS BY REGION, THROUGH 2019 ($ MILLIONS)
      • TABLE 17: GLOBAL MARKET SHARES FOR INHALERS BY REGION, 2013 (%)
      • TABLE 18: FORECAST GLOBAL MARKET SHARES FOR INHALERS BY REGION, 2019 (%)
    • GLOBAL MARKET FOR RESPIRATORS
      • TABLE 19: GLOBAL MARKET FOR RESPIRATORS BY REGION, THROUGH 2019 ($ MILLIONS)
      • TABLE 20: GLOBAL MARKET SHARES FOR RESPIRATORS BY REGION, 2013 (%)
      • TABLE 21: FORECAST GLOBAL MARKET SHARES FOR RESPIRATORS BY REGION, 2019 (%)
      • TABLE 22: GLOBAL NEBULIZER, INHALER AND RESPIRATOR MARKET BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 4: GLOBAL NEBULIZER, INHALER AND RESPIRATOR MARKET BY DEVICE TYPE, 2013-2019 ($ MILLIONS)
      • TABLE 23: GLOBAL MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2013 (%)
      • TABLE 24: FORECAST GLOBAL MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2019 (%)

CHAPTER 6 - PATENTS

  • RECENTLY AWARDED PATENTS
    • TABLE 25: RECENTLY AWARDED NEBULIZER PATENTS, 2002-2014
    • TABLE 26: RECENTLY AWARDED INHALER PATENTS, 2002-2013
    • TABLE 27: RECENTLY AWARDED RESPIRATOR PATENTS, 2001-2011
    • TABLE 28: RECENTLY AWARDED ASTHMATIC DEVICE PATENTS, 2004

CHAPTER 7 - REGULATIONS AND REIMBURSEMENT

  • OVERVIEW
  • CERTIFICATE OF FREE SALE FOR MEDICAL DEVICES
    • TABLE 29: MEDICAL DEVICE REGULATORY AGENCIES BY COUNTRY
  • GLOBAL HARMONIZATION TASK FORCE (GHTF)
  • INTERNATIONAL MEDICAL DEVICE REGULATORS FORUM
  • MEDICAL DEVICE REGULATIONS BY REGION/COUNTRY
    • NORTH AMERICA
      • United States
        • Deficit Reduction Act
      • Canada
    • EUROPEAN UNION
      • Medical Devices Directive
      • New Legislation on Medical Devices in the EU
      • Medical Device Regulations by Country/Region
        • France
        • Germany
        • Italy
        • Spain
        • United Kingdom
        • Benelux
          • Belgium
          • The Netherlands
          • Luxembourg
        • Scandinavia
          • Norway
          • Denmark
          • Sweden
    • ASIA
      • Japan
      • China
      • India
    • EMERGING MARKETS
      • Australia
      • Brazil
      • Israel
      • Russia
  • REIMBURSEMENT CHALLENGES
    • OVERVIEW OF REIMBURSEMENT PROCEDURES BY REGION/COUNTRY
      • North America
        • United States
        • Canada
      • Europe
        • France
        • Germany
        • Italy
        • Spain
        • United Kingdom
        • Benelux
          • Belgium
          • The Netherlands
          • Luxembourg
        • Scandinavia
          • Norway
          • Denmark
          • Sweden
      • Asia
        • India
        • China
        • Japan
      • Emerging Markets
        • Australia
        • Brazil
        • Israel
        • Russia
  • FUTURE TECHNOLOGICAL DEVELOPMENTS
    • BRONCHIAL THERMOPLASTY (BT)
    • PIMOZIDE RESEARCH
    • SMART NEBULIZERS
    • OVER-THE-COUNTER ASTHMA INHALERS
    • DOURESP SPIROMAX
    • NEW DRUGS FROM ASTRAZENECA
    • HYGIENE HYPOTHESIS

CHAPTER 8 - HEALTHCARE IN THE NORTH AMERICAN, EUROPEAN, ASIAN AND EMERGING MARKETS

  • THE NORTH AMERICAN MARKET
    • UNITED STATES
      • TABLE 30: U.S. HEALTHCARE EXPENDITURES COMPARED TO SELECTED COUNTRIES (% OF GDP)
      • TABLE 31: U.S. SOCIAL SECURITY PAYMENTS AND INFORMATION, 2012-2013
      • State Children's Health Insurance Program
      • The Veteran's Administration
        • TABLE 32: DOCTORS' VISITS BY CONDITION, 2012 (% OF TOTAL VISITS)
      • Asthma Statistics
      • Oregon Report on Asthma
      • Low Carbon Fuel Standard Program
      • Alternative Medicine
        • TABLE 33: U.S. MARKET SHARES BY COMPANY, 2013 ($ MILLIONS/%)
      • U.S. Elderly Population Demographics
        • TABLE 34: U.S. ELDERLY POPULATION BY AGE GROUP, 2000-2050
    • CANADA
      • Alternative Medicine in Canada
      • Canadian Elderly Population Demographics
        • TABLE 35: ELDERLY POPULATION IN CANADA BY AGE GROUP, 2000-2050
  • NORTH AMERICAN ASTHMA TREATMENT DEVICE MARKET
    • United States
      • Nebulizers
        • TABLE 36: U.S. NEBULIZER MARKET, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • Inhalers
        • TABLE 37: U.S. INHALER MARKET, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • Respirators
        • TABLE 38: U.S. RESPIRATOR MARKET, THROUGH 2019 ($ MILLIONS/THOUSANDS)
        • TABLE 39: U.S. NEBULIZER, INHALER AND RESPIRATOR MARKET BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
        • TABLE 40: U.S. MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2013 (%)
        • TABLE 41: U.S. MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2019 (%)
    • Canada
      • TABLE 42: GUIDELINES FOR ASSESSING A CHILD IN RESPIRATORY STRESS
      • Nebulizers
        • TABLE 43: NEBULIZER MARKET IN CANADA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • Inhalers
        • TABLE 44: INHALER MARKET IN CANADA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • Respirators
        • TABLE 45: RESPIRATOR MARKET IN CANADA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • Summary of the Canadian Market
        • TABLE 46: NEBULIZER, INHALER AND RESPIRATOR MARKET IN CANADA BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
        • TABLE 47: CANADIAN MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2013 (%)
        • TABLE 48: CANADIAN MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2019 (%)
      • Summary of the North American Market
        • TABLE 49: NORTH AMERICAN MARKET FOR NEBULIZERS, INHALERS AND RESPIRATORS, THROUGH 2019 ($ MILLIONS/THOUSANDS)
        • TABLE 50: NORTH AMERICAN NEBULIZER, INHALER AND RESPIRATOR MARKET BY COUNTRY, THROUGH 2019 ($ MILLIONS)
  • THE EUROPEAN MARKET
    • TABLE 51: HEALTHCARE EXPENDITURES BY COUNTRY (% OF GDP/$)
    • EUROPEAN APHEKOM PROJECT
    • EUROPEAN ELDERLY POPULATION DEMOGRAPHICS
    • EUROPEAN ASTHMA STATISTICS
      • TABLE 52: ESTIMATED COST OF RESPIRATORY DISEASES FOR THE EUROPEAN HEALTHCARE SECTOR ($ BILLIONS)
      • TABLE 53: EUROPEAN COST BURDEN OF RESPIRATORY DISEASES ($ BILLIONS)
      • TABLE 54: STATISTICS OF EUROPEAN BURDEN OF RESPIRATORY DISEASES ($)
      • Sales of PMDIs Compared with DPIs
  • DEMOGRAPHICS BY COUNTRY
    • France
      • TABLE 55: ASTHMA TREATMENT COSTS IN FRANCE ($ MILLIONS)
      • Tackling Pollution
      • France's Elderly Population Demographics
        • TABLE 56: ELDERLY POPULATION OF FRANCE BY AGE GROUP, 2000-2050
    • Germany
      • German Elderly Population Demographics
        • TABLE 57: ELDERLY POPULATION OF GERMANY BY AGE GROUP, 2000-2050
    • Italy
      • Italian Elderly Population Demographics
        • TABLE 58: ELDERLY POPULATION OF ITALY BY AGE GROUP, 2000-2050
    • Spain
      • Spanish Elderly Population Demographics
        • TABLE 59: ELDERLY POPULATION IN SPAIN BY AGE GROUP, 2000-2050
    • United Kingdom
      • TABLE 60: U.K. PUBLIC SPENDING PROJECTED TO 2015 ($ BILLIONS)
      • TABLE 61: NUMBER OF PEOPLE TREATED FOR ASTHMA ACROSS THE U.K., BY REGION (NUMBER)
      • U.K. Elderly Population Demographics
        • TABLE 62: ELDERLY POPULATION IN THE U.K. BY AGE GROUP, 2000-2050
    • Benelux
      • The Netherlands
      • The Netherlands Elderly Population Demographics
        • TABLE 63: ELDERLY POPULATION IN THE NETHERLANDS BY AGE GROUP, 2000-2050
    • Belgium
      • Belgian Elderly Population Demographics
        • TABLE 64: ELDERLY POPULATION IN BELGIUM BY AGE GROUP, 2000-2050
    • Luxembourg
      • Luxembourg Elderly Population Demographics
        • TABLE 65: ELDERLY POPULATION IN LUXEMBOURG BY AGE GROUP, 2000-2050
    • Scandinavia
      • Norway
      • Norwegian Elderly Population Demographics
        • TABLE 66: ELDERLY POPULATION IN NORWAY BY AGE GROUP, 2000-2050
    • Denmark
      • Danish Elderly Population Demographics
        • TABLE 67: ELDERLY POPULATION IN DENMARK BY AGE GROUP, 2000-2050
    • Sweden
      • Swedish Elderly Population Demographics
        • TABLE 68: ELDERLY POPULATION IN SWEDEN BY AGE GROUP, 2000-2050
  • SIZE AND GROWTH OF THE EUROPEAN ASTHMA TREATMENT DEVICE MARKET
    • TABLE 69: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET BY REGION/COUNTRY, THROUGH 2019 ($ MILLIONS)
    • FIGURE 5: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET BY REGION/COUNTRY, 2013-2019 ($ MILLIONS)
    • TABLE 70: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 6: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET SHARES, 2013-2019 ($ MILLIONS)
    • TABLE 71: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET SHARES, 2013 (%)
    • TABLE 72: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET SHARES, 2019 (%)
    • European Asthma Treatment Device Market by Country
      • TABLE 73: EUROPEAN MARKET SHARE BY COMPANY, 2013 ($ MILLIONS/%)
    • France
      • TABLE 74: NEBULIZER MARKET IN FRANCE, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 75: INHALER MARKET IN FRANCE, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 76: RESPIRATOR MARKET IN FRANCE, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 77: NEBULIZER, INHALER AND RESPIRATOR MARKET IN FRANCE, BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • Germany
      • TABLE 78: NEBULIZER MARKET IN GERMANY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 79: INHALER MARKET IN GERMANY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 80: RESPIRATOR MARKET IN GERMANY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 81: NEBULIZER, INHALER AND RESPIRATOR MARKET IN GERMANY BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • Italy
      • TABLE 82: NEBULIZER MARKET IN ITALY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 83: INHALER MARKET IN ITALY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 84: RESPIRATOR MARKET IN ITALY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 85: NEBULIZER, INHALER AND RESPIRATOR MARKET IN ITALY BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • Spain
      • TABLE 86: NEBULIZER MARKET IN SPAIN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 87: INHALER MARKET IN SPAIN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 88: RESPIRATOR MARKET IN SPAIN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 89: NEBULIZER, INHALER AND RESPIRATOR MARKET IN SPAIN BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • United Kingdom
      • TABLE 90: NEBULIZER MARKET IN THE U.K., THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 91: INHALER MARKET IN THE U.K., THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 92: RESPIRATOR MARKET IN THE U.K., THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 93: NEBULIZER, INHALER AND RESPIRATOR MARKET IN THE U.K. BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • Scandinavia
      • TABLE 94: NEBULIZER MARKET IN SCANDINAVIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 95: INHALER MARKET IN SCANDINAVIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 96: RESPIRATOR MARKET IN SCANDINAVIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 97: NEBULIZER, INHALER AND RESPIRATOR MARKET IN SCANDINAVIA BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • Benelux
      • TABLE 98: NEBULIZER MARKET IN BENELUX, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 99: INHALER MARKET IN BENELUX, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 100: RESPIRATOR MARKET IN BENELUX, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 101: NEBULIZER, INHALER AND RESPIRATOR MARKET IN BENELUX BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
  • THE ASIAN MARKET
    • INDIA
      • TABLE 102: HEALTHCARE FOR ALL DECLARATIONS/ENDORSEMENTS/GOALS
      • Alternative Medicine
      • India's Elderly Population Demographics
        • TABLE 103: POPULATION GROWTH IN INDIA, 1960-2013 (MILLIONS)
        • TABLE 104: PROJECTED POPULATION OF INDIA, 2015-2050 (MILLIONS/%)
        • TABLE 105: ELDERLY POPULATION IN INDIA BY AGE GROUP, 2000-2050
    • CHINA
      • Tackling Pollution
      • Herbal Treatment for Asthma
      • Population of China
        • TABLE 106: POPULATION IN CHINA BY REGION, 2013
        • TABLE 107: POPULATION IN CHINA BY CITY, 2010-2013
        • TABLE 108: POPULATION OF CHINA, 1950-2010
        • TABLE 109: PROJECTED POPULATION OF CHINA, 2020-2100
      • Chinese Elderly Population Demographics
        • TABLE 110: ELDERLY POPULATION IN CHINA BY AGE GROUP, 2000-2050
    • JAPAN
      • Herbal Treatment for Asthma
      • Japanese Elderly Population Demographics
        • TABLE 111: ELDERLY POPULATION IN JAPAN BY AGE GROUP, 2000-2050
    • MARKET FOR ASTHMA TREATMENT DEVICES IN ASIA
      • Nebulizers
        • TABLE 112: ASIAN NEBULIZER MARKET BY COUNTRY, THROUGH 2019 ($ MILLIONS)
      • Inhalers
        • TABLE 113: ASIAN INHALER MARKET BY COUNTRY, THROUGH 2019 ($ MILLIONS)
      • Respirators
        • TABLE 114: ASIAN RESPIRATOR MARKET BY COUNTRY, THROUGH 2019 ($ MILLIONS)
        • TABLE 115: ASIAN NEBULIZER, INHALER AND RESPIRATOR MARKET BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
        • TABLE 116: ASIAN MARKET SHARES OF NEBULIZERS, RESPIRATORS AND INHALERS, 2013 (%)
        • TABLE 117: ASIAN MARKET SHARES OF NEBULIZERS, RESPIRATORS AND INHALERS, 2019 (%)
      • Expansion into Asia
        • TABLE 118: ASIAN AND EMERGING MARKET SHARES BY SELECTED COMPANIES, 2013 ($ MILLIONS/%)
      • Asian Asthma Treatment Device Market by Country
        • India
          • TABLE 119: NEBULIZER MARKET IN INDIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
          • TABLE 120: INHALER MARKET IN INDIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
          • TABLE 121: RESPIRATOR MARKET IN INDIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
          • TABLE 122: NEBULIZER, INHALER AND RESPIRATOR MARKET IN INDIA BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
        • China
          • TABLE 123: NEBULIZER MARKET IN CHINA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
          • TABLE 124: INHALER MARKET IN CHINA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
          • TABLE 125: RESPIRATOR MARKET IN CHINA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
          • TABLE 126: NEBULIZER, INHALER AND RESPIRATOR MARKET IN CHINA BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
        • Japan
          • TABLE 127: NEBULIZER MARKET IN JAPAN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
          • TABLE 128: INHALER MARKET IN JAPAN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
          • TABLE 129: RESPIRATOR MARKET IN JAPAN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
          • TABLE 130: NEBULIZER, INHALER AND RESPIRATOR MARKET IN JAPAN BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
  • EMERGING MARKETS
    • AUSTRALIA
      • TABLE 131: ALLOCATED EXPENDITURES ON ASTHMA IN AUSTRALIA BY AGE AND GENDER, 2008 ($ MILLIONS)
      • Australian Elderly Population Demographics
        • TABLE 132: ELDERLY POPULATION IN AUSTRALIA BY AGE GROUP, 2000-2050
    • BRAZIL
      • Brazilian Elderly Population Demographics
        • TABLE 133: ELDERLY POPULATION IN BRAZIL BY AGE GROUP, 2000-2050
    • ISRAEL
      • Israeli Elderly Population Demographics
        • TABLE 134: ELDERLY POPULATION IN ISRAEL BY AGE GROUP, 2000-2050
    • RUSSIA
      • Russian Elderly Population Demographics
        • TABLE 135: ELDERLY POPULATION IN RUSSIA BY AGE GROUP, 2000-2050
  • THE EMERGING MARKETS ASTHMA TREATMENT DEVICE MARKET
    • TABLE 136: EMERGING MARKETS NEBULIZER, INHALER AND RESPIRATOR MARKET BY COUNTRY, THROUGH 2019 ($ MILLIONS)
    • TABLE 137: NEBULIZER, INHALER AND RESPIRATOR MARKET SHARES IN EMERGING MARKETS BY COUNTRY, 2013 (%)
    • TABLE 138: NEBULIZER, INHALER AND RESPIRATOR MARKET SHARES IN EMERGING MARKETS BY COUNTRY, 2019 (%)
    • TABLE 139: NEBULIZER, INHALER AND RESPIRATOR MARKET IN EMERGING MARKETS BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • Australia
      • TABLE 140: NEBULIZER MARKET IN AUSTRALIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 141: INHALER MARKET IN AUSTRALIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 142: RESPIRATOR MARKET IN AUSTRALIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 143: NEBULIZER, INHALER AND RESPIRATOR MARKET IN AUSTRALIA BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • Brazil
      • TABLE 144: NEBULIZER MARKET IN BRAZIL, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 145: INHALER MARKET IN BRAZIL, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 146: RESPIRATOR MARKET IN BRAZIL, THROUGH 2019
      • TABLE 147: NEBULIZER, INHALER AND RESPIRATORS MARKET IN BRAZIL BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • Israel
      • TABLE 148: NEBULIZER MARKET IN ISRAEL, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 149: INHALER MARKET IN ISRAEL, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 150: RESPIRATOR MARKET IN ISRAEL, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 151: MARKET OF NEBULIZERS, INHALERS AND RESPIRATORS IN ISRAEL BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • Russia
      • TABLE 152: NEBULIZER, INHALER AND RESPIRATOR MARKET IN RUSSIA BY DEVICE TYPE, 2013-2019 ($ MILLIONS)
      • TABLE 153: NEBULIZER MARKET IN RUSSIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 154: INHALER MARKET IN RUSSIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
      • TABLE 155: RESPIRATOR MARKET IN RUSSIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)

CHAPTER 9 - MARKET STRATEGIES AND STRATEGIC RECOMMENDATIONS

  • MARKETING STRATEGIES
    • EMPLOY A MARKETING COMPANY
    • INCREASE EXPOSURE
    • R&D AND PATIENT POWER
  • PATENT STRATEGIES
  • ADDRESSING PRIMARY CONCERNS
  • JOINT VENTURES

CHAPTER 10 - PRESENT SITUATION

  • OVERVIEW OF ASTHMA
  • THE GLOBAL ASTHMA NETWORK
  • DRUG USAGE WITH ASTHMA TREATMENT DEVICES
  • OBESITY AND RESPIRATORY DISEASES
    • TABLE 156: OBESITY FIGURES AND ASSOCIATED DEATHS, 2013 ($ BILLIONS)
    • TABLE 157: STUDIES ON THE RELATIONSHIP BETWEEN AHR AND BMI
  • MEDICAL TREATMENT DEVICES FOR RESPIRATORY DISEASES
    • NEBULIZERS
      • Using a Nebulizer
      • Jet Nebulizers
      • Compressor Nebulizers
    • INHALERS
    • RESPIRATORS

CHAPTER 11 - COMPANY PROFILES

  • 3M HEALTHCARE
  • ASTRAZENECA
    • TABLE 158: ASTRAZENECA'S RESPIRATORY PRODUCTS
  • BOEHRINGER INGELHEIM
    • OVERVIEW
  • DRAGER
  • GLAXOSMITHKLINE
  • INVACARE
  • OMRON
  • PHILIPS RESPIRONICS
  • PHILIPS HEALTHCARE

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR NEBULIZERS, INHALERS AND RESPIRATORS FOR TREATMENT OF ASTHMA BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 1: COLOR CODING OF INHALERS
    • TABLE 2: NIOSH STANDARDS FOR PARTICULATE FILTER RESPIRATORS (%)
    • TABLE 3: EUROPEAN STANDARD EN143 RESPIRATOR FILTER (%)
    • TABLE 4: EUROPEAN STANDARD EN149 RESPIRATOR
    • TABLE 5: EUROPEAN STANARD EN136 FULL FACE MASK
    • TABLE 6: ENVIRONMENTAL PROTECTION AGENCY (EPA) AIR QUALITY INDEX
    • TABLE 7: COST OF INDIVIDUAL NEBULIZERS BY COUNTRY ($)
    • TABLE 8: GLOBAL MARKET FOR NEBULIZERS, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 9: COST OF INHALERS BY COUNTRY ($)
    • TABLE 10: GLOBAL MARKET FOR INHALERS, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 11: COST OF RESPIRATORS BY COUNTRY ($)
    • TABLE 12: GLOBAL MARKET FOR RESPIRATORS, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 13: GLOBAL MARKET FOR NEBULIZERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 14: GLOBAL MARKET SHARES FOR NEBULIZERS BY REGION, 2013 (%)
    • TABLE 15: FORECAST GLOBAL MARKET SHARES FOR NEBULIZERS BY REGION, 2019 (%)
    • TABLE 16: GLOBAL MARKET FOR INHALERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 17: GLOBAL MARKET SHARES FOR INHALERS BY REGION, 2013 (%)
    • TABLE 18: FORECAST GLOBAL MARKET SHARES FOR INHALERS BY REGION, 2019 (%)
    • TABLE 19: GLOBAL MARKET FOR RESPIRATORS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 20: GLOBAL MARKET SHARES FOR RESPIRATORS BY REGION, 2013 (%)
    • TABLE 21: FORECAST GLOBAL MARKET SHARES FOR RESPIRATORS BY REGION, 2019 (%)
    • TABLE 22: GLOBAL NEBULIZER, INHALER AND RESPIRATOR MARKET BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 23: GLOBAL MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2013 (%)
    • TABLE 24: FORECAST GLOBAL MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2019 (%)
    • TABLE 25: RECENTLY AWARDED NEBULIZER PATENTS, 2002-2014
    • TABLE 26: RECENTLY AWARDED INHALER PATENTS, 2002-2013
    • TABLE 27: RECENTLY AWARDED RESPIRATOR PATENTS, 2001-2011
    • TABLE 28: RECENTLY AWARDED ASTHMATIC DEVICE PATENTS, 2004
    • TABLE 29: MEDICAL DEVICE REGULATORY AGENCIES BY COUNTRY
    • TABLE 30: U.S. HEALTHCARE EXPENDITURES COMPARED TO SELECTED COUNTRIES (% OF GDP)
    • TABLE 31: U.S. SOCIAL SECURITY PAYMENTS AND INFORMATION, 2012-2013
    • TABLE 32: DOCTORS' VISITS BY CONDITION, 2012 (% OF TOTAL VISITS)
    • TABLE 33: U.S. MARKET SHARES BY COMPANY, 2013 ($ MILLIONS/%)
    • TABLE 34: U.S. ELDERLY POPULATION BY AGE GROUP, 2000-2050
    • TABLE 35: ELDERLY POPULATION IN CANADA BY AGE GROUP, 2000-2050
    • TABLE 36: U.S. NEBULIZER MARKET, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 37: U.S. INHALER MARKET, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 38: U.S. RESPIRATOR MARKET, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 39: U.S. NEBULIZER, INHALER AND RESPIRATOR MARKET BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 40: U.S. MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2013 (%)
    • TABLE 41: U.S. MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2019 (%)
    • TABLE 42: GUIDELINES FOR ASSESSING A CHILD IN RESPIRATORY STRESS
    • TABLE 43: NEBULIZER MARKET IN CANADA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 44: INHALER MARKET IN CANADA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 45: RESPIRATOR MARKET IN CANADA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 46: NEBULIZER, INHALER AND RESPIRATOR MARKET IN CANADA BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 47: CANADIAN MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2013 (%)
    • TABLE 48: CANADIAN MARKET SHARES OF NEBULIZERS, INHALERS AND RESPIRATORS, 2019 (%)
    • TABLE 49: NORTH AMERICAN MARKET FOR NEBULIZERS, INHALERS AND RESPIRATORS, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 50: NORTH AMERICAN NEBULIZER, INHALER AND RESPIRATOR MARKET BY COUNTRY, THROUGH 2019 ($ MILLIONS)
    • TABLE 51: HEALTHCARE EXPENDITURES BY COUNTRY (% OF GDP/$)
    • TABLE 52: ESTIMATED COST OF RESPIRATORY DISEASES FOR THE EUROPEAN HEALTHCARE SECTOR ($ BILLIONS)
    • TABLE 53: EUROPEAN COST BURDEN OF RESPIRATORY DISEASES ($ BILLIONS)
    • TABLE 54: STATISTICS OF EUROPEAN BURDEN OF RESPIRATORY DISEASES ($)
    • TABLE 55: ASTHMA TREATMENT COSTS IN FRANCE ($ MILLIONS)
    • TABLE 56: ELDERLY POPULATION OF FRANCE BY AGE GROUP, 2000-2050
    • TABLE 57: ELDERLY POPULATION OF GERMANY BY AGE GROUP, 2000-2050
    • TABLE 58: ELDERLY POPULATION OF ITALY BY AGE GROUP, 2000-2050
    • TABLE 59: ELDERLY POPULATION IN SPAIN BY AGE GROUP, 2000-2050
    • TABLE 60: U.K. PUBLIC SPENDING PROJECTED TO 2015 ($ BILLIONS)
    • TABLE 61: NUMBER OF PEOPLE TREATED FOR ASTHMA ACROSS THE U.K., BY REGION (NUMBER)
    • TABLE 62: ELDERLY POPULATION IN THE U.K. BY AGE GROUP, 2000-2050
    • TABLE 63: ELDERLY POPULATION IN THE NETHERLANDS BY AGE GROUP, 2000-2050
    • TABLE 64: ELDERLY POPULATION IN BELGIUM BY AGE GROUP, 2000-2050
    • TABLE 65: ELDERLY POPULATION IN LUXEMBOURG BY AGE GROUP, 2000-2050
    • TABLE 66: ELDERLY POPULATION IN NORWAY BY AGE GROUP, 2000-2050
    • TABLE 67: ELDERLY POPULATION IN DENMARK BY AGE GROUP, 2000-2050
    • TABLE 68: ELDERLY POPULATION IN SWEDEN BY AGE GROUP, 2000-2050
    • TABLE 69: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET BY REGION/COUNTRY, THROUGH 2019 ($ MILLIONS)
    • TABLE 70: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 71: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET SHARES, 2013 (%)
    • TABLE 72: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET SHARES, 2019 (%)
    • TABLE 73: EUROPEAN MARKET SHARE BY COMPANY, 2013 ($ MILLIONS/%)
    • TABLE 74: NEBULIZER MARKET IN FRANCE, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 75: INHALER MARKET IN FRANCE, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 76: RESPIRATOR MARKET IN FRANCE, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 77: NEBULIZER, INHALER AND RESPIRATOR MARKET IN FRANCE, BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 78: NEBULIZER MARKET IN GERMANY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 79: INHALER MARKET IN GERMANY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 80: RESPIRATOR MARKET IN GERMANY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 81: NEBULIZER, INHALER AND RESPIRATOR MARKET IN GERMANY BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 82: NEBULIZER MARKET IN ITALY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 83: INHALER MARKET IN ITALY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 84: RESPIRATOR MARKET IN ITALY, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 85: NEBULIZER, INHALER AND RESPIRATOR MARKET IN ITALY BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 86: NEBULIZER MARKET IN SPAIN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 87: INHALER MARKET IN SPAIN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 88: RESPIRATOR MARKET IN SPAIN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 89: NEBULIZER, INHALER AND RESPIRATOR MARKET IN SPAIN BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 90: NEBULIZER MARKET IN THE U.K., THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 91: INHALER MARKET IN THE U.K., THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 92: RESPIRATOR MARKET IN THE U.K., THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 93: NEBULIZER, INHALER AND RESPIRATOR MARKET IN THE U.K. BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 94: NEBULIZER MARKET IN SCANDINAVIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 95: INHALER MARKET IN SCANDINAVIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 96: RESPIRATOR MARKET IN SCANDINAVIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 97: NEBULIZER, INHALER AND RESPIRATOR MARKET IN SCANDINAVIA BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 98: NEBULIZER MARKET IN BENELUX, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 99: INHALER MARKET IN BENELUX, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 100: RESPIRATOR MARKET IN BENELUX, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 101: NEBULIZER, INHALER AND RESPIRATOR MARKET IN BENELUX BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 102: HEALTHCARE FOR ALL DECLARATIONS/ENDORSEMENTS/GOALS
    • TABLE 103: POPULATION GROWTH IN INDIA, 1960-2013 (MILLIONS)
    • TABLE 104: PROJECTED POPULATION OF INDIA, 2015-2050 (MILLIONS/%)
    • TABLE 105: ELDERLY POPULATION IN INDIA BY AGE GROUP, 2000-2050
    • TABLE 106: POPULATION IN CHINA BY REGION, 2013
    • TABLE 107: POPULATION IN CHINA BY CITY, 2010-2013
    • TABLE 108: POPULATION OF CHINA, 1950-2010
    • TABLE 109: PROJECTED POPULATION OF CHINA, 2020-2100
    • TABLE 110: ELDERLY POPULATION IN CHINA BY AGE GROUP, 2000-2050
    • TABLE 111: ELDERLY POPULATION IN JAPAN BY AGE GROUP, 2000-2050
    • TABLE 112: ASIAN NEBULIZER MARKET BY COUNTRY, THROUGH 2019 ($ MILLIONS)
    • TABLE 113: ASIAN INHALER MARKET BY COUNTRY, THROUGH 2019 ($ MILLIONS)
    • TABLE 114: ASIAN RESPIRATOR MARKET BY COUNTRY, THROUGH 2019 ($ MILLIONS)
    • TABLE 115: ASIAN NEBULIZER, INHALER AND RESPIRATOR MARKET BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 116: ASIAN MARKET SHARES OF NEBULIZERS, RESPIRATORS AND INHALERS, 2013 (%)
    • TABLE 117: ASIAN MARKET SHARES OF NEBULIZERS, RESPIRATORS AND INHALERS, 2019 (%)
    • TABLE 118: ASIAN AND EMERGING MARKET SHARES BY SELECTED COMPANIES, 2013 ($ MILLIONS/%)
    • TABLE 119: NEBULIZER MARKET IN INDIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 120: INHALER MARKET IN INDIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 121: RESPIRATOR MARKET IN INDIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 122: NEBULIZER, INHALER AND RESPIRATOR MARKET IN INDIA BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 123: NEBULIZER MARKET IN CHINA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 124: INHALER MARKET IN CHINA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 125: RESPIRATOR MARKET IN CHINA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 126: NEBULIZER, INHALER AND RESPIRATOR MARKET IN CHINA BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 127: NEBULIZER MARKET IN JAPAN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 128: INHALER MARKET IN JAPAN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 129: RESPIRATOR MARKET IN JAPAN, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 130: NEBULIZER, INHALER AND RESPIRATOR MARKET IN JAPAN BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 131: ALLOCATED EXPENDITURES ON ASTHMA IN AUSTRALIA BY AGE AND GENDER, 2008 ($ MILLIONS)
    • TABLE 132: ELDERLY POPULATION IN AUSTRALIA BY AGE GROUP, 2000-2050
    • TABLE 133: ELDERLY POPULATION IN BRAZIL BY AGE GROUP, 2000-2050
    • TABLE 134: ELDERLY POPULATION IN ISRAEL BY AGE GROUP, 2000-2050
    • TABLE 135: ELDERLY POPULATION IN RUSSIA BY AGE GROUP, 2000-2050
    • TABLE 136: EMERGING MARKETS NEBULIZER, INHALER AND RESPIRATOR MARKET BY COUNTRY, THROUGH 2019 ($ MILLIONS)
    • TABLE 137: NEBULIZER, INHALER AND RESPIRATOR MARKET SHARES IN EMERGING MARKETS BY COUNTRY, 2013 (%)
    • TABLE 138: NEBULIZER, INHALER AND RESPIRATOR MARKET SHARES IN EMERGING MARKETS BY COUNTRY, 2019 (%)
    • TABLE 139: NEBULIZER, INHALER AND RESPIRATOR MARKET IN EMERGING MARKETS BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 140: NEBULIZER MARKET IN AUSTRALIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 141: INHALER MARKET IN AUSTRALIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 142: RESPIRATOR MARKET IN AUSTRALIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 143: NEBULIZER, INHALER AND RESPIRATOR MARKET IN AUSTRALIA BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 144: NEBULIZER MARKET IN BRAZIL, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 145: INHALER MARKET IN BRAZIL, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 146: RESPIRATOR MARKET IN BRAZIL, THROUGH 2019
    • TABLE 147: NEBULIZER, INHALER AND RESPIRATORS MARKET IN BRAZIL BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 148: NEBULIZER MARKET IN ISRAEL, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 149: INHALER MARKET IN ISRAEL, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 150: RESPIRATOR MARKET IN ISRAEL, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 151: MARKET OF NEBULIZERS, INHALERS AND RESPIRATORS IN ISRAEL BY DEVICE TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 152: NEBULIZER, INHALER AND RESPIRATOR MARKET IN RUSSIA BY DEVICE TYPE, 2013-2019 ($ MILLIONS)
    • TABLE 153: NEBULIZER MARKET IN RUSSIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 154: INHALER MARKET IN RUSSIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 155: RESPIRATOR MARKET IN RUSSIA, THROUGH 2019 ($ MILLIONS/THOUSANDS)
    • TABLE 156: OBESITY FIGURES AND ASSOCIATED DEATHS, 2013 ($ BILLIONS)
    • TABLE 157: STUDIES ON THE RELATIONSHIP BETWEEN AHR AND BMI
    • TABLE 158: ASTRAZENECA'S RESPIRATORY PRODUCTS

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR NEBULIZERS, INHALERS AND RESPIRATORS FOR TREATMENT OF ASTHMA BY REGION, 2013-2019 ($ MILLIONS)
    • FIGURE 1: GLOBAL MARKET FOR NEBULIZERS, 2013-2019 ($ MILLIONS)
    • FIGURE 2: GLOBAL MARKET FOR INHALERS, 2013-2019 ($ MILLIONS)
    • FIGURE 3: GLOBAL MARKET FOR RESPIRATORS, 2013-2019 ($ MILLIONS)
    • FIGURE 4: GLOBAL NEBULIZER, INHALER AND RESPIRATOR MARKET BY DEVICE TYPE, 2013-2019 ($ MILLIONS)
    • FIGURE 5: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET BY REGION/COUNTRY, 2013-2019 ($ MILLIONS)
    • FIGURE 6: EUROPEAN NEBULIZER, INHALER AND RESPIRATOR MARKET SHARES, 2013-2019 ($ MILLIONS)
Back to Top